{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T15:57:35Z","timestamp":1773244655673,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIHR Comprehensive Biomedical Research Centre"}],"content-domain":{"domain":["ejcancer.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ejca.2013.11.024","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T21:47:58Z","timestamp":1386712078000},"page":"690-697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["When is a completion axillary lymph node dissection necessary in the presence of a positive sentinel lymph node?"],"prefix":"10.1016","volume":"50","author":[{"given":"A.","family":"Suyoi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.K.","family":"Bains","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Douek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Agbaje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Fentiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Pinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.D.","family":"Purushotham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ejca.2013.11.024_b0005","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa020989","article-title":"Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer","volume":"347","author":"Veronesi","year":"2002","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.ejca.2013.11.024_b0010","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejca.2013.11.024_b0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S1470-2045(12)70042-6","article-title":"Breast conserving therapy versus mastectomy for stage I\u2013II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial","volume":"13","author":"Litiere","year":"2012","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2013.11.024_b0020","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2013.11.024_b0025","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejca.2013.11.024_b0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","article-title":"Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer","volume":"95","author":"Fleissig","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.ejca.2013.11.024_b0035","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.ejca.2013.11.024_b0040","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"24","key":"10.1016\/j.ejca.2013.11.024_b0045","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011","volume":"25","author":"Lucci","year":"2007","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2013.11.024_b0050","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejso.2007.05.017","article-title":"Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial","volume":"34","author":"Del Bianco","year":"2008","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2013.11.024_b0055","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","article-title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial","volume":"8","author":"Krag","year":"2007","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2013.11.024_b0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1245\/s10434-011-1823-z","article-title":"A 10-year trend analysis of sentinel lymph node frozen section and completion axillary dissection for breast cancer: are these procedures becoming obsolete?","volume":"19","author":"Weber","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"19","key":"10.1016\/j.ejca.2013.11.024_b0065","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1200\/JCO.2005.03.228","article-title":"Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial","volume":"23","author":"Purushotham","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2013.11.024_b0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10549-009-0705-6","article-title":"Outcome of axillary staging in early breast cancer: a meta-analysis","volume":"120","author":"Kell","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"30","key":"10.1016\/j.ejca.2013.11.024_b0075","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","article-title":"American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer","volume":"23","author":"Lyman","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.11.024_b0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.yasu.2011.03.015","article-title":"Local and regional control in breast cancer: role of sentinel node biopsy","volume":"45","author":"Giuliano","year":"2011","journal-title":"Adv Surg"},{"issue":"11","key":"10.1016\/j.ejca.2013.11.024_b0085","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jnci\/djh142","article-title":"Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates","volume":"96","author":"McCready","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.ejca.2013.11.024_b0090","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1200\/JCO.2007.14.4667","article-title":"Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases","volume":"26","author":"Rutgers","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2013.11.024_b0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2013.11.024_b0100","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ejca.2013.11.024_b0105","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2013.11.024_b0110","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1245\/ASO.2005.08.020","article-title":"The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer","volume":"12","author":"Fan","year":"2005","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2013.11.024_b0115","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.sla.0000128302.05898.a7","article-title":"Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection","volume":"239","author":"Fournier","year":"2004","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejca.2013.11.024_b0120","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10549-011-1486-2","article-title":"Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?","volume":"131","author":"Galimberti","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.ejca.2013.11.024_b0125","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","article-title":"Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000","volume":"20","author":"Sola","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2013.11.024_b0130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/cncr.23514","article-title":"How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?","volume":"113","author":"Yi","year":"2008","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2013.11.024_b0135","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.amjsurg.2012.01.010","article-title":"Revisiting the \u201810% rule\u2019 in breast cancer sentinel lymph node biopsy: an approach to minimize the number of sentinel lymph nodes removed","volume":"203","author":"Dutta","year":"2012","journal-title":"Am J Surg"},{"issue":"4","key":"10.1016\/j.ejca.2013.11.024_b0140","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4048\/jbc.2011.14.4.296","article-title":"How many sentinel lymph nodes are enough for accurate axillary staging in t1\u20132 breast cancer?","volume":"14","author":"Ban","year":"2011","journal-title":"J Breast Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2013.11.024_b0145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.6004\/jnccn.2009.0012","article-title":"Breast cancer. Clinical practice guidelines in oncology","volume":"7","author":"Carlson","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"10.1016\/j.ejca.2013.11.024_b0150","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/1097-0142(19951101)76:9<1491::AID-CNCR2820760902>3.0.CO;2-8","article-title":"Axillary lymph nodes and breast cancer. A review","volume":"76","author":"Recht","year":"1995","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2013.11.024_b0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1096-9098(199901)70:1<13::AID-JSO3>3.0.CO;2-Z","article-title":"Clinical observations of axillary involvement for tubular, lobular, and ductal carcinomas of the breast","volume":"70","author":"Leonard","year":"1999","journal-title":"J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2013.11.024_b0160","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1245\/ASO.2003.03.015","article-title":"A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy","volume":"10","author":"Van Zee","year":"2003","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2013.11.024_b0165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10549-004-5781-z","article-title":"An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement","volume":"91","author":"Barranger","year":"2005","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"10.1016\/j.ejca.2013.11.024_b0170","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1200\/JCO.1993.11.10.1936","article-title":"Clinical significance of HER-2\/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group","volume":"11","author":"Seshadri","year":"1993","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.ejca.2013.11.024_b0175","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1056\/NEJMp058197","article-title":"The distinctive nature of HER2-positive breast cancers","volume":"353","author":"Burstein","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejca.2013.11.024_b0180","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1245\/ASO.2003.05.020","article-title":"Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer","volume":"10","author":"Hwang","year":"2003","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2013.11.024_b0185","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/bjs.5943","article-title":"A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive","volume":"95","author":"Pal","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2013.11.024_b0190","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2407-8-66","article-title":"New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients","volume":"8","author":"Kohrt","year":"2008","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2013.11.024_b0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.critrevonc.2010.06.008","article-title":"Management strategy of early-stage breast cancer patients with a positive sentinel lymph node: with or without axillary lymph node dissection","volume":"79","author":"Chen","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"10.1016\/j.ejca.2013.11.024_b0200","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1742-1241.2008.01887.x","article-title":"Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system","volume":"62","author":"Unal","year":"2008","journal-title":"Int J Clin Pract"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804913010204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804913010204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T12:37:36Z","timestamp":1647693456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804913010204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0959804913010204"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2013.11.024","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When is a completion axillary lymph node dissection necessary in the presence of a positive sentinel lymph node?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2013.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}